Newage publishes major new discovery on blocking spike proteins from binding to human cells

Denver, oct. 07, 2021 (globe newswire) -- newage, inc. (nasdaq: nbev), the colorado-based organic and healthy products company, today announced that it has discovered and isolated the mechanism of action to block spike proteins from binding to cells in the human body.   the company believes the discovery to be of major significance and intends to both leverage the science within its own portfolio and to also partner with other medical, research, or pharma companies and health systems to enable the benefits of the discovery to become more broadly available to consumers worldwide.
NBEV Ratings Summary
NBEV Quant Ranking